Xbrane Biopharma AB Cash Flow Quality Index

Latest as of June 2025: -0.38x

Xbrane Biopharma AB cash flow quality index. Xbrane Biopharma AB (XBRANE) has a Cash Flow Quality Index of -0.38x as of June 2025. Operating cash flow of Skr-65.06 Million is below net income of Skr171.81 Million, suggesting accrual-heavy earnings not yet converted to cash. See financial agility of Xbrane Biopharma AB to measure the company's free cash flow as a share of total liabilities.

Cash Flow Quality Index

-0.38x

Operating CF / Net Income

Operating Cash Flow

Skr-65.06 Million

SEK

Net Income

Skr171.81 Million

SEK

Data as of

Jun 2025

Most recent filing

Xbrane Biopharma AB Cash Flow Quality Index by Year (None–None)

Xbrane Biopharma AB cash flow quality index by year from None to None. Year-by-year earnings quality comparison for Xbrane Biopharma AB. For the full cash flow conversion analysis, see Xbrane Biopharma AB cash flow conversion.

Year	Quality Index	Operating CF (SEK)	Net Income	YoY Change

Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.